Advertisement

Current Diabetes Reports

, 11:552 | Cite as

Gene × Environment Interactions in Type 2 Diabetes

  • Paul W. FranksEmail author
Genetics (Jose C. Florez, Section Editor)

Abstract

People vary genetically in their susceptibility to the effects of environmental risk factors for many diseases. Genetic variation also underlies the extent to which people respond appropriately to clinical therapies. Defining the basis to the interactions between the genome and the environment may help elucidate the biologic basis to diseases such as type 2 diabetes, as well as help target preventive therapies and treatments. This review examines 1) some of the most current evidence on gene × environment interactions in relation to type 2 diabetes; 2) outlines how the availability of information on gene × environment interactions might help improve the prevention and treatment of type 2 diabetes; and 3) discusses existing and emerging strategies that might enhance our ability to detect and exploit gene × environment interactions in complex disease traits.

Keywords

Gene Environment interaction Type 2 diabetes 

Notes

Acknowledgments

The author’s research is supported by grants from the Swedish Diabetes Association, Novo Nordisk, the Swedish Heart-Lung Foundation, the Swedish Research Council, the European Union, and the National Institutes of Health. The author thanks Dr. F. Renström for her careful critique of this manuscript prior to publication.

Disclosure

Conflicts of interest: P.W. Franks: has served on the boards for INSERM, LifeGene SAB, and the German National Cohort; has received honoraria from Novo Nordisk; and has received payment for multiple book chapters and review articles.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
  2. 2.
    Fox CS, Coady S, Sorlie PD, D’Agostino Sr RB, Pencina MJ, Vasan RS, et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007;115:1544–50.PubMedCrossRefGoogle Scholar
  3. 3.
    Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34.PubMedCrossRefGoogle Scholar
  4. 4.
    Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.PubMedCrossRefGoogle Scholar
  5. 5.
    Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.PubMedCrossRefGoogle Scholar
  6. 6.
    Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–86.PubMedCrossRefGoogle Scholar
  7. 7.
    Baron AL. Facet number in Drosophila melanogaster as influenced by certain genetic and environmental factors. J Exp Zool. 1935;70:461–90.CrossRefGoogle Scholar
  8. 8.
    Jacob F, Monod J. Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol. 1961;3:318–56.PubMedCrossRefGoogle Scholar
  9. 9.
  10. 10.
    •• The InterAct Consortium. Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia. 2011;54(9):2272–82. The InterAct Study is a European-based nested case-cohort study designed for the detection of gene x lifestyle interactions in type 2 diabetes. The study is the largest and most comprehensive of its kind to date involving around 12,500 incident cases and 16,000 non-cases selected from a background population of around a third of a million people. CrossRefGoogle Scholar
  11. 11.
    Prentice AM. Early influences on human energy regulation: thrifty genotypes and thrifty phenotypes. Physiol Behav. 2005;86:640–5.PubMedCrossRefGoogle Scholar
  12. 12.
    • Speakman JR. Thrifty genes for obesity, an attractive but flawed idea, and an alternative perspective: the ‘drifty gene’ hypothesis. Int J Obes. 2008;32:1611–7. This is an opinion piece arguing against the selection of so-called thrifty genes in the human gene pool. CrossRefGoogle Scholar
  13. 13.
    Bouchard C, Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc. 2001;33:S446–51. discussion S452-443.PubMedCrossRefGoogle Scholar
  14. 14.
    Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D’Agostino Sr RB. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med. 2007;167:1068–74.PubMedCrossRefGoogle Scholar
  15. 15.
    Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008;359:2220–32.PubMedCrossRefGoogle Scholar
  16. 16.
    Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008;359:2208–19.PubMedCrossRefGoogle Scholar
  17. 17.
    de Miguel-Yanes JM, Shrader P, Pencina MJ, Fox CS, Manning AK, Grant RW, et al. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care. 2011;34:121–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Lu Q, Elston RC. Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes. Am J Hum Genet. 2008;82:641–51.PubMedCrossRefGoogle Scholar
  19. 19.
    Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature. 2008;454:463–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature. 2002;418:797–801.PubMedCrossRefGoogle Scholar
  21. 21.
    Russell AP, Feilchenfeldt J, Schreiber S, Praz M, Crettenand A, Gobelet C, et al. Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. Diabetes. 2003;52:2874–81.PubMedCrossRefGoogle Scholar
  22. 22.
    Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA. 2003;100:8466–71.PubMedCrossRefGoogle Scholar
  23. 23.
    Franks PW, Loos RJ. PGC-1alpha gene and physical activity in type 2 diabetes mellitus. Exerc Sport Sci Rev. 2006;34:171–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Barroso I, Luan J, Sandhu MS, Franks PW, Crowley V, Schafer AJ, et al. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia. 2006;49:501–5.PubMedCrossRefGoogle Scholar
  25. 25.
    • Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42:579–89. This is a recent report from the DIAGRAM+ consortium summarizing the findings from meta-analyses of GWAS data. The report outlines association signals for more than 30 replicated loci. PubMedCrossRefGoogle Scholar
  26. 26.
    Franks PW, Barroso I, Luan J, Ekelund U, Crowley VEF, Sandhu MS, et al. Wareham NJ PGC-1a genotype modifies the association of volitional energy expenditure with VO2max. Med Sci Sports Exerc. 2003;35(12):1998–2004.PubMedCrossRefGoogle Scholar
  27. 27.
    Ridderstråle M, Johansson LE, Rastam L, Lindblad U. Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men. Diabetologia. 2006;49(3):496–500.PubMedCrossRefGoogle Scholar
  28. 28.
    Franks PW, Ekelund U, Brage S, Luan J, Schafer AJ, O’Rahilly S, et al. Wareham NJ PPARGC1A coding variation may initiate impaired NEFA clearance during glucose challenge. Diabetologia. 2007;50(3):569–73.PubMedCrossRefGoogle Scholar
  29. 29.
    Nelson TL, Fingerlin TE, Moss L, Barmada MM, Ferrell RE, Norris JM. The peroxisome proliferator-activated receptor gamma coactivator-1 alpha gene (PGC-1alpha) is not associated with type 2 diabetes mellitus or body mass index among Hispanic and non Hispanic Whites from Colorado. Exp Clin Endocrinol Diabetes. 2007;115(4):268–75.PubMedCrossRefGoogle Scholar
  30. 30.
    Stefan N, Thamer C, Staiger H, Machicao F, Machann J, Schick F, et al. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention. J Clin Endocrinol Metab. 2007;92(5):1827–33.PubMedCrossRefGoogle Scholar
  31. 31.
    Brito EC, Vimaleswaran VK, Brage S, Andersen LB, Sardinha LB, Wareham NJ, et al. PPARGC1A sequence variation and cardiovascular risk-factor levels: a study of main genetic effects and gene x environment interactions in children from the European Youth Heart Study. Diabetologia. 2009;52(4):609–13.PubMedCrossRefGoogle Scholar
  32. 32.
    Bray MS, Hagberg JM, Perusse L, Rankinen T, Roth SM, Wolfarth B, et al. The human gene map for performance and health-related fitness phenotypes: the 2006–2007 update. Med Sci Sports Exerc. 2009;41:35–73.PubMedGoogle Scholar
  33. 33.
    Kooperberg C, Leblanc M. Increasing the power of identifying gene x gene interactions in genome-wide association studies. Genet Epidemiol. 2008;32:255–63.PubMedCrossRefGoogle Scholar
  34. 34.
    • Brito EC, Lyssenko V, Renstrom F, Berglund G, Nilsson PM, Groop L, et al. Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: a study of 16,003 Swedish adults. Diabetes. 2009;58:1411–8. This is a comprehensive assessment of genetic variation at the PPARGC1A locus in relation to cardiovascular and metabolic quantitative traits and their interactions with physical activity in more than 2000 European school children. PubMedCrossRefGoogle Scholar
  35. 35.
    Moore AF, Jablonski KA, McAteer JB, Saxena R, Pollin TI, Franks PW, et al. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes. 2008;57:2503–10.PubMedCrossRefGoogle Scholar
  36. 36.
    • Ruchat SM, Rankinen T, Weisnagel SJ, Rice T, Rao DC, Bergman RN, et al. Improvements in glucose homeostasis in response to regular exercise are influenced by the PPARG Pro12Ala variant: results from the HERITAGE Family Study. Diabetologia. 2010;53:679–89. This is an analysis of eight variants in seven type 2 diabetes genes in relation to a range of quantitative traits derived from an intravenous glucose tolerance test before and after 20 weeks of aerobic conditioning exercise. PubMedCrossRefGoogle Scholar
  37. 37.
    Luan J, Browne PO, Harding AH, Halsall DJ, O’Rahilly S, Chatterjee VK, et al. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes. 2001;50:686–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC, et al. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet. 2003;12:2923–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Franks PW, Mesa JL, Harding AH, Wareham NJ. Gene-lifestyle interaction on risk of type 2 diabetes. Nutr Metab Cardiovasc Dis. 2007;17:104–24.PubMedCrossRefGoogle Scholar
  40. 40.
    •• Palla L, Higgins JP, Wareham NJ, Sharp SJ. Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. Am J Epidemiol. 2010;171:1225–32. This is a paper that discusses the practical and methodologic limitations of conducting literature-based meta-analyses of GEI studies. PubMedCrossRefGoogle Scholar
  41. 41.
    Nelson TL, Fingerlin TE, Moss LK, Barmada MM, Ferrell RE, Norris JM. Association of the peroxisome proliferator-activated receptor gamma gene with type 2 diabetes mellitus varies by physical activity among non-Hispanic whites from Colorado. Metabolism: clinical and experimental. 2007;56:388–93.CrossRefGoogle Scholar
  42. 42.
    Florez JC, Jablonski KA, Sun MW, Bayley N, Kahn SE, Shamoon H, et al. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. J Clin Endocrinol Metab. 2007;92:1502–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Lindi VI, Uusitupa MI, Lindstrom J, et al. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes. 2002;51:2581–6.PubMedCrossRefGoogle Scholar
  44. 44.
    Kilpelainen TO, Lakka TA, Laaksonen DE, et al. SNPs in PPARG associate with type 2 diabetes and interact with physical activity. Med Sci Sports Exerc. 2008;40:25–33.PubMedGoogle Scholar
  45. 45.
    Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889–94.PubMedCrossRefGoogle Scholar
  46. 46.
    Andreasen CH, Stender-Petersen KL, Mogensen MS, et al. Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes. 2008;57:95–101.PubMedCrossRefGoogle Scholar
  47. 47.
    Rampersaud E, Mitchell BD, Pollin TI, et al. Physical activity and the association of common FTO gene variants with body mass index and obesity. Arch Intern Med. 2008;168:1791–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Franks PW, Jablonski KA, Delahanty LM, McAteer JB, Kahn SE, Knowler WC, et al. Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia. 2008;51:2214–23.PubMedCrossRefGoogle Scholar
  49. 49.
    •• Nettleton JA, McKeown NM, Kanoni S, et al. Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care. 2010;33:2684–91. This is a large-scale meta-analysis of data on gene x nutrient (dietary whole grains) interactions in relation to fasting insulin and glucose concentrations. The study identified a variant at the GCKR locus that showed tentative evidence of gene x nutrient interactions. PubMedCrossRefGoogle Scholar
  50. 50.
    •• Kanoni S, Nettleton JA, Hivert MF, et al. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. diabetes 2011 (epublished Aug 1). This is a large-scale meta-analysis of data on gene x zinc (dietary and supplemental) interactions in relation to fasting insulin and glucose concentrations. The study identified a variant at the SLC30A8 locus, a gene encoding a zinc transporter, that showed tentative evidence of gene x nutrient interactions. Google Scholar
  51. 51.
    Rutter GA. Think zinc: new roles for zinc in the control of insulin secretion. Islets. 2010;2:49–50.PubMedCrossRefGoogle Scholar
  52. 52.
    • Franks PW, Brito EC. Interaction between exercise and genetics in type 2 diabetes mellitus: an epidemiological perspective. In: Roth SM, Pescatello L, editors. Exercise genomics: molecular & translational medicine. Springer Science: Clifton; 2011. This is a systematic review of literature on gene x exercise interactions related to type 2 diabetes. Google Scholar
  53. 53.
    •• Franks PW, Nettleton JA. Invited commentary: gene X lifestyle interactions and complex disease traits—inferring cause and effect from observational data, sine qua non. Am J Epidemiol. 2010;172:992–7; discussion 998–999. This is an editorial commentary discussing causal inference in epidemiologic studies of gene x lifestyle interactions. Google Scholar
  54. 54.
    • Moore JH, Asselbergs FW, Williams SM. Bioinformatics challenges for genome-wide association studies. Bioinformatics. 2010;26:445–55. This is an overview of the limitations of GWAS, including discussion of why such studies are poorly suited to the discovery of GEIs. PubMedCrossRefGoogle Scholar
  55. 55.
    •• Pare G, Cook NR, Ridker PM, Chasman DI. On the use of variance per genotype as a tool to identify quantitative trait interaction effects: a report from the Women’s Genome Health Study. PLoS Genet. 2010;6:e1000981. This is a paper that describes and tests an agnostic method for the detection of GEIs. The authors identified several novel interactions using this method in the Women’s Genome Health Study. PubMedCrossRefGoogle Scholar
  56. 56.
    Ridker PM, Chasman DI, Zee RY, Parker A, Rose L, Cook NR, et al. Rationale, design, and methodology of the Women’s Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. Clin Chem. 2008;54:249–55.PubMedCrossRefGoogle Scholar
  57. 57.
    Boks MP, Schipper M, Schubart CD, Sommer IE, Kahn RS, Ophoff RA. Investigating gene environment interaction in complex diseases: increasing power by selective sampling for environmental exposure. Int J Epidemiol. 2007;36:1363–9.PubMedCrossRefGoogle Scholar
  58. 58.
    Wong MY, Day NE, Luan JA, Wareham NJ. Estimation of magnitude in gene-environment interactions in the presence of measurement error. Stat Med. 2004;23:987–98.PubMedCrossRefGoogle Scholar
  59. 59.
    •• Manning AK, LaValley M, Liu CT, Rice K, An P, Liu Y, et al. Meta-analysis of gene-environment interaction: joint estimation of SNP and SNP x environment regression coefficients. Genet Epidemiol. 2011;35:11–8. This is a paper describing and applying an adaptation of the 2 d.f. method for jointly studying interactions (between a genetic and environmental risk factor) and genetic main effects. The method, known as JMA, along with others were tested using data from multiple cohorts in which PPARG had been tagged and these variants tested for interactions with BMI on fasting insulin levels. PubMedCrossRefGoogle Scholar
  60. 60.
    • Chatterjee N, Wacholder S. Invited commentary: efficient testing of gene-environment interaction. Am J Epidemiol. 2009;169:231–3; discussion 234–235. This is a paper describing methods upon which Manning et al. [59••] builds. Google Scholar
  61. 61.
    Kraft P, Yen YC, Stram DO, Morrison J, Gauderman WJ. Exploiting gene-environment interaction to detect genetic associations. Hum Hered. 2007;63:111–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Becker BJ, Wu MJ. The synthesis of regression slopes in meta-analysis. Stat Sci. 2007;22:414–29.CrossRefGoogle Scholar
  63. 63.
    Wareham NJ, Franks PW, Harding AH. Establishing the role of gene-environment interactions in the etiology of type 2 diabetes. Endocrinol Metab Clin North Am. 2002;31:553–66.PubMedCrossRefGoogle Scholar
  64. 64.
    Franks PW. The interaction of genetic factors and physical activity energy expenditure in the aetiology of the metabolic syndrome. In: Department of community medicine. Cambridge, Cambridge University; 2003, p. 490.Google Scholar
  65. 65.
    Renström F, Payne F, Nordström A, Brito EC, Rolandsson O, Hallmans G, et al. the GIANT consortium. Replication and extension of genome-wide association study results for obesity in 4,923 adults from Northern Sweden. Hum Mol Genet. 2009;18(8):1489–96.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Clinical Sciences, Genetic & Molecular Epidemiology UnitSkåne University Hospital MalmöMalmöSweden

Personalised recommendations